Cardiol Therapeutics Revenue

Revenue

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

144.33M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	78.76K	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	-	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Curaleaf Holdings	1.78B
dentalcorp Holdings	1.66B
Trulieve Cannabis	1.66B
Green Thumb Industries	1.61B
Extendicare	1.59B
WELL Health Technologies	1.25B
Sienna Senior Living	967.05M
Vireo Growth	263.65M

Revenue Rankings

Cardiol Therapeutics News

11 days ago - Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040 - Newsfile Corp
19 days ago - Cardiol Therapeutics' Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases - Newsfile Corp
4 weeks ago - Cardiol Therapeutics Completes US$11.4 Million Financing and Extends Cash Runway into Q3 2027 - Newsfile Corp
5 weeks ago - Cardiol Therapeutics Secures US$11 Million Financing and Extends Cash Runway into Q3 2027 - Newsfile Corp
3 months ago - Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity's 45th Annual Growth Conference - Newsfile Corp
3 months ago - Cardiol Therapeutics Announces Topline Results from the Phase II ARCHER Trial of CardiolRx(TM) in Acute Myocarditis - Newsfile Corp
4 months ago - Cardiol Therapeutics Announces Database Lock for Phase II ARCHER Trial of CardiolRx(TM) in Acute Myocarditis - Newsfile Corp
6 months ago - Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders - Newsfile Corp

More News